{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T03:46:27Z","timestamp":1785728787423,"version":"3.56.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prev Sci"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s11121-026-01933-z","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:50:09Z","timestamp":1779411009000},"page":"927-936","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of Test Strips for Detection of Fentanyl in Powders"],"prefix":"10.1007","volume":"27","author":[{"given":"Jessica L.","family":"Armstrong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3027-3811","authenticated-orcid":false,"given":"Rebekah E.","family":"Wharton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"#cr-split#-1933_CR1.1","unstructured":"Armbrecht, E., Guzauskas, G., Hansen R., Pandey, R., Fazioli, K., Chapman, R., Pearson, S. D., & Rind, D. M. (2021). Supervised injection facilities and other supervised consumption sites: Effectiveness and value"},{"key":"#cr-split#-1933_CR1.2","unstructured":"Final evidence report. Institute for Clinical and Economic Review.\u00a0Retrieved April 22, 2025, from\u00a0http:\/\/resource.nlm.nih.gov\/9918230986806676"},{"key":"1933_CR2","unstructured":"CCSA. (2024). Supervised consumption sites.\u00a0Retrieved April 22, 2025, from\u00a0https:\/\/www.ccsa.ca\/sites\/default\/files\/2024-10\/SCS-Evidence-Brief-en.pdf"},{"key":"1933_CR3","unstructured":"CDC. (2024a). Lifesaving naloxone.\u00a0Retrieved April 22, 2025, from\u00a0https:\/\/www.cdc.gov\/stop-overdose\/caring\/naloxone.html"},{"key":"1933_CR4","unstructured":"CDC. (2024b). OD2A Case study: Harm reduction.\u00a0Retrieved April 22, 2025, from https:\/\/www.cdc.gov\/overdose-prevention\/php\/od2a\/harm-reduction.html"},{"key":"1933_CR5","unstructured":"CDC. (2024c). Overdose data to action: Prevention strategies.\u00a0Retrieved April 22, 2025, from https:\/\/www.cdc.gov\/overdose-prevention\/php\/od2a\/prevention.html"},{"key":"1933_CR6","unstructured":"CDC. (2024d). Understanding the opioid overdose epidemic. Overdose Prevention.\u00a0Retrieved April 22, 2025, from https:\/\/www.cdc.gov\/overdose-prevention\/about\/understanding-the-opioid-overdose-epidemic.html"},{"key":"1933_CR7","unstructured":"CDC. (2024e). What You can do to test for fentanyl.\u00a0Retrieved April 22, 2025, from https:\/\/www.cdc.gov\/stop-overdose\/safety\/index.html"},{"key":"1933_CR8","unstructured":"CDC. (2025). SUDORS dashboard: Fatal drug overdose data \u2013 accessible version. Overdose Prevention. Retrieved April 30 from https:\/\/www.cdc.gov\/overdose-prevention\/data-research\/facts-stats\/sudors-dashboard-fatal-overdose-data-accessible.html. Dec 12, 2024."},{"key":"1933_CR9","unstructured":"CDC National Center for Health Statisticsision of Analysis and Epidemiology.\u00a0(2023). Drug overdose deaths.\u00a0Retrieved April 23, 2025, from\u00a0https:\/\/www.cdc.gov\/nchs\/hus\/topics\/drug-overdose-deaths.htm"},{"key":"1933_CR10","unstructured":"Clark, S., Yolken, A., & DeToy, S. (2021). Escalating overdose deaths necessitate an overdose prevention center in Rhode Island.\u00a0Rhode Island Medical Journal\u00a0(2013), 104(2), 18\u201320.\u00a0Retrieved April 22, 2025, from https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33648313"},{"key":"1933_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neubiorev.2018.12.005","volume":"106","author":"SD Comer","year":"2019","unstructured":"Comer, S. D., & Cahill, C. M. (2019). Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment. Neuroscience and Biobehavioral Reviews, 106, 49\u201357. https:\/\/doi.org\/10.1016\/j.neubiorev.2018.12.005","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"1933_CR12","unstructured":"DEA. (2022). Fentanyl. Retrieved April 22, 2025 from https:\/\/www.dea.gov\/sites\/default\/files\/2022-12\/Fentanyl%202022%20Drug%20Fact%20Sheet.pdf"},{"key":"1933_CR13","unstructured":"DEA. (2024a). Drug enforcement administration national drug threat assessment 2024. Retrieved April 21, 2025 from https:\/\/www.dea.gov\/documents\/2024\/2024-05\/2024-05-24\/national-drug-threat-assessment-2024"},{"key":"1933_CR14","unstructured":"DEA. (2024b). DEA STREET May 2024: State and territory report on enduring and emerging threats (NIIP-029\u201324). (State and Territory Report on Enduring and Emerging Threats, Issue.\u00a0Retrieved April 21, 2025, from\u00a0https:\/\/www.dea.gov\/sites\/default\/files\/2024-07\/Street%20Report%20-%20May%202024.pdf"},{"key":"1933_CR15","unstructured":"DEA. (2024c). DEA STREET Janurary 2024: State and territory report on enduring and emerging threats (NIIP-012\u201324). (State and Territory Report on Enduring and Emerging Threats, Issue.\u00a0Retrieved April 21, 2025, from\u00a0https:\/\/www.dea.gov\/sites\/default\/files\/2024-01\/Street%20Report%20-%20Jan%202024%20-%20FINAL.pdf"},{"key":"1933_CR16","unstructured":"DEA-NFLIS. (2023). NFLIS-drug brief: Substances co-reported with fentanyl in NFLIS-drug and DEA-Tox, January 2013\u2013June 2023 (DEA PRB 2023\u201320). (National Forensic Laboratory Information System - Drug, Issue.\u00a0Retrieved April 30, 2024, from\u00a0https:\/\/www.nflis.deadiversion.usdoj.gov\/nflisdata\/docs\/15431NFLISDrugBriefFentanyl.pdf"},{"issue":"1","key":"1933_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-018-0276-0","volume":"16","author":"JE Goldman","year":"2019","unstructured":"Goldman, J. E., Waye, K. M., Periera, K. A., Krieger, M. S., Yedinak, J. L., & Marshall, B. D. L. (2019). Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: A qualitative study. Harm Reduction Journal, 16(1), Article 3. https:\/\/doi.org\/10.1186\/s12954-018-0276-0","journal-title":"Harm Reduction Journal"},{"issue":"1","key":"1933_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12954-023-00921-8","volume":"21","author":"JC Halifax","year":"2024","unstructured":"Halifax, J. C., Lim, L., Ciccarone, D., & Lynch, K. L. (2024). Testing the test strips: Laboratory performance of fentanyl test strips. Harm Reduction Journal, 21(1), 14. https:\/\/doi.org\/10.1186\/s12954-023-00921-8","journal-title":"Harm Reduction Journal"},{"issue":"1","key":"1933_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12954-023-00911-w","volume":"20","author":"KL Hayes","year":"2023","unstructured":"Hayes, K. L., & Lieberman, M. (2023). Assessment of two brands of fentanyl test strips with 251 synthetic opioids reveals \u201cblind spots\u201d in detection capabilities. Harm Reduction Journal, 20(1), 175. https:\/\/doi.org\/10.1186\/s12954-023-00911-w","journal-title":"Harm Reduction Journal"},{"issue":"1","key":"1933_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-018-0252-8","volume":"15","author":"M Karamouzian","year":"2018","unstructured":"Karamouzian, M., Dohoo, C., Forsting, S., McNeil, R., Kerr, T., & Lysyshyn, M. (2018). Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada. Harm Reduction Journal, 15(1), Article 46. https:\/\/doi.org\/10.1186\/s12954-018-0252-8","journal-title":"Harm Reduction Journal"},{"issue":"10361","key":"1933_CR21","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/S0140-6736(22)01593-8","volume":"400","author":"MC Kennedy","year":"2022","unstructured":"Kennedy, M. C., Karamouzian, M., & Marshall, B. D. L. (2022). The North American opioid crisis: How effective are supervised consumption sites? Lancet, 400(10361), 1403\u20131404. https:\/\/doi.org\/10.1016\/S0140-6736(22)01593-8","journal-title":"Lancet"},{"issue":"4","key":"1933_CR22","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1176\/appi.ps.201800398","volume":"70","author":"A Kennedy-Hendricks","year":"2019","unstructured":"Kennedy-Hendricks, A., Bluestein, J., Kral, A. H., Barry, C. L., & Sherman, S. G. (2019). Establishing sanctioned safe consumption sites in the United States: Five jurisdictions moving the policy agenda forward. Psychiatric Services, 70(4), 294\u2013301. https:\/\/doi.org\/10.1176\/appi.ps.201800398","journal-title":"Psychiatric Services"},{"issue":"4","key":"1933_CR23","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1177\/29767342241253663","volume":"45","author":"K Koehm","year":"2024","unstructured":"Koehm, K., Rosen, J. G., Yedinak Gray, J. L., Tardif, J., Thompson, E., & Park, J. N. (2024). \u201cPolitics versus policy\u201d: Qualitative insights on stigma and overdose prevention center policymaking in the United States. Subst Use Addctn J, 45(4), 682\u2013689. https:\/\/doi.org\/10.1177\/29767342241253663","journal-title":"Subst Use Addctn J"},{"key":"1933_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.drugpo.2018.09.009","volume":"61","author":"MS Krieger","year":"2018","unstructured":"Krieger, M. S., Goedel, W. C., Buxton, J. A., Lysyshyn, M., Bernstein, E., Sherman, S. G., Rich, J. D., Hadland, S. E., Green, T. C., & Marshall, B. D. L. (2018). Use of rapid fentanyl test strips among young adults who use drugs. International Journal of Drug Policy, 61, 52\u201358. https:\/\/doi.org\/10.1016\/j.drugpo.2018.09.009","journal-title":"International Journal of Drug Policy"},{"key":"1933_CR25","unstructured":"Krotulski, A. P. D. M., Walton, S. E., Fogarty, M. F., & Logan, B. K. (2022). NPS discovery: Year in review 2022.\u00a0Retrieved April 23, 2025, from\u00a0https:\/\/www.cfsre.org\/images\/trendreports\/yir-2022\/2022_Year%20In%20Review_NPS%20Discovery_010623.pdf"},{"key":"1933_CR26","unstructured":"Krotulski, A. P. D. M., Walton, S. E., DeBord, J. S, Fogarty, M. F., & Logan, B. K. (2023). NPS discovery: Year in review 2023.\u00a0Retrieved April 22, 2025, from\u00a0https:\/\/www.cfsre.org\/images\/trendreports\/yir-2023\/2023_Year_In_Review_CFSRE_NPS_Discovery_010824.pdf"},{"key":"1933_CR27","unstructured":"Leonard, N. (2023). Philadelphia City Council passes near-total ban on future supervised consumption, overdose prevention sites. WHYY News.\u00a0Retrieved April 23, 2025, from\u00a0https:\/\/whyy.org\/articles\/philadelphia-city-council-passes-near-total-ban-on-future-safe-consumption-overdose-prevention-sites\/"},{"issue":"1","key":"1933_CR28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12954-021-00478-4","volume":"18","author":"TE Lockwood","year":"2021","unstructured":"Lockwood, T. E., Vervoordt, A., & Lieberman, M. (2021). High concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips. Harm Reduction Journal, 18(1), 30. https:\/\/doi.org\/10.1186\/s12954-021-00478-4","journal-title":"Harm Reduction Journal"},{"key":"1933_CR29","unstructured":"Lynch, K. (2023). UCSF fentanyl test strip study \u2013 Summary.\u00a0Retrieved April 22, 2025, from\u00a0https:\/\/dancesafe.org\/ucsf-fentanyl-study\/"},{"key":"1933_CR30","unstructured":"McCarthy, L.-J. (2023). FDA approves first over-the-counter naloxone nasal spray.\u00a0Retrieved April 23, 2025, from\u00a0https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-over-counter-naloxone-nasal-spray"},{"issue":"5-6","key":"1933_CR31","doi-asserted-by":"publisher","first-page":"740","DOI":"10.17269\/s41997-018-0126-6","volume":"109","author":"SC Mema","year":"2018","unstructured":"Mema, S. C., Sage, C., Xu, Y., Tupper, K. W., Ziemianowicz, D., McCrae, K., Leigh, M., Munn, M. B., Taylor, D., & Corneil, T. (2018). Drug checking at an electronic dance music festival during the public health overdose emergency in British Columbia. Canadian Journal of Public Health, 109(5\u20136), 740\u2013744. https:\/\/doi.org\/10.17269\/s41997-018-0126-6","journal-title":"Canadian Journal of Public Health"},{"key":"1933_CR32","unstructured":"NIDA. (2022). Naloxone DrugFacts. National Institute for Health.\u00a0Retrieved April 22, 2025, from\u00a0https:\/\/nida.nih.gov\/publications\/drugfacts\/naloxone"},{"key":"1933_CR33","unstructured":"NIDA. (2023a). Drug checking. National Institute for Health.\u00a0Retrieved April 22, 2025, from https:\/\/nida.nih.gov\/research-topics\/drug-checking"},{"key":"1933_CR34","unstructured":"NIDA. (2023b). Overdose prevention centers. National Institute for Health.\u00a0Retrieved April 22, 2025, from https:\/\/nida.nih.gov\/research-topics\/overdose-prevention-centers"},{"key":"1933_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102787","volume":"82","author":"H Oh","year":"2020","unstructured":"Oh, H., Kim, K., Miller, D., Veloso, D., Lin, J., & McFarland, W. (2020). Fentanyl self-testing in a community-based sample of people who inject drugs, San Francisco. International Journal of Drug Policy, 82, Article 102787. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102787","journal-title":"International Journal of Drug Policy"},{"issue":"Suppl 6","key":"1933_CR36","doi-asserted-by":"publisher","first-page":"S343","DOI":"10.1097\/PHH.0000000000001576","volume":"28","author":"R Olson","year":"2022","unstructured":"Olson, R., Case, P., Palacios, W. R., Hunter, A., Lopes-McCoy, V., & Green, T. C. (2022). Law enforcement and community provision of fentanyl test strips to people who use drugs for engagement and referral to services. Journal of Public Health Management and Practice, 28(Suppl 6), S343\u2013S346. https:\/\/doi.org\/10.1097\/PHH.0000000000001576","journal-title":"Journal of Public Health Management and Practice"},{"key":"1933_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103196","volume":"94","author":"JN Park","year":"2021","unstructured":"Park, J. N., Frankel, S., Morris, M., Dieni, O., Fahey-Morrison, L., Luta, M., Hunt, D., Long, J., & Sherman, S. G. (2021). Evaluation of fentanyl test strip distribution in two Mid-Atlantic syringe services programs. International Journal of Drug Policy, 94, Article 103196. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103196","journal-title":"International Journal of Drug Policy"},{"key":"1933_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2020.106529","volume":"110","author":"JN Park","year":"2020","unstructured":"Park, J. N., Tomko, C., Silberzahn, B. E., Haney, K., Marshall, B. D. L., & Sherman, S. G. (2020). A fentanyl test strip intervention to reduce overdose risk among female sex workers who use drugs in Baltimore: Results from a pilot study. Addictive Behaviors, 110, Article 106529. https:\/\/doi.org\/10.1016\/j.addbeh.2020.106529","journal-title":"Addictive Behaviors"},{"key":"1933_CR39","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.drugpo.2018.08.007","volume":"63","author":"NC Peiper","year":"2019","unstructured":"Peiper, N. C., Clarke, S. D., Vincent, L. B., Ciccarone, D., Kral, A. H., & Zibbell, J. E. (2019). Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States. International Journal of Drug Policy, 63, 122\u2013128. https:\/\/doi.org\/10.1016\/j.drugpo.2018.08.007","journal-title":"International Journal of Drug Policy"},{"issue":"5","key":"1933_CR40","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1111\/jcpt.13362","volume":"46","author":"JV Pergolizzi Jr.","year":"2021","unstructured":"Pergolizzi, J. V., Jr., Dahan, A., LeQuang, J. A., & Raffa, R. B. (2021b). The conundrum of polysubstance overdose. Journal of Clinical Pharmacy and Therapeutics, 46(5), 1189\u20131193. https:\/\/doi.org\/10.1111\/jcpt.13362","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"issue":"8","key":"1933_CR41","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.17496","volume":"13","author":"J Pergolizzi","year":"2021","unstructured":"Pergolizzi, J., Magnusson, P., LeQuang, J. A. K., & Breve, F. (2021a). Illicitly manufactured fentanyl entering the United States. Cureus, 13(8), Article e17496. https:\/\/doi.org\/10.7759\/cureus.17496","journal-title":"Cureus"},{"issue":"1","key":"1933_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-025-01181-4","volume":"22","author":"CJ Piercey","year":"2025","unstructured":"Piercey, C. J., Schlechter, T. E., Henry, D., Allen-Collins, M., Ahern, R., Cameron, J., Conner, B. T., Snodgrass, J. G., & Karoly, H. C. (2025). Use of reagent test kits and fentanyl test strips among electronic music festival attendees in Colorado: Prevalence, barriers, and behavior in response to drug checking. Harm Reduction Journal, 22(1), Article 46. https:\/\/doi.org\/10.1186\/s12954-025-01181-4","journal-title":"Harm Reduction Journal"},{"issue":"5","key":"1933_CR43","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3109\/15563659509013752","volume":"33","author":"A Poklis","year":"1995","unstructured":"Poklis, A. (1995). Fentanyl: A review for clinical and analytical toxicologists. Journal of Toxicology. Clinical Toxicology, 33(5), 439\u2013447. https:\/\/doi.org\/10.3109\/15563659509013752","journal-title":"Journal of Toxicology. Clinical Toxicology"},{"issue":"2","key":"1933_CR44","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1016\/S2468-2667(23)00300-6","volume":"9","author":"I Rammohan","year":"2024","unstructured":"Rammohan, I., Gaines, T., Scheim, A., Bayoumi, A., & Werb, D. (2024). Overdose mortality incidence and supervised consumption services in Toronto, Canada: An ecological study and spatial analysis. Lancet Public Health, 9(2), e79\u2013e87. https:\/\/doi.org\/10.1016\/S2468-2667(23)00300-6","journal-title":"Lancet Public Health"},{"key":"1933_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103643","volume":"103","author":"MK Reed","year":"2022","unstructured":"Reed, M. K., Guth, A., Salcedo, V. J., Hom, J. K., & Rising, K. L. (2022). \u201cYou can\u2019t go wrong being safe\u201d: Motivations, patterns, and context surrounding use of fentanyl test strips for heroin and other drugs. International Journal of Drug Policy, 103, Article 103643. https:\/\/doi.org\/10.1016\/j.drugpo.2022.103643","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"1933_CR46","doi-asserted-by":"publisher","first-page":"36","DOI":"10.23907\/2017.004","volume":"7","author":"HE Schueler","year":"2017","unstructured":"Schueler, H. E. (2017). Emerging synthetic fentanyl analogs. Academic Forensic Pathology, 7(1), 36\u201340. https:\/\/doi.org\/10.23907\/2017.004","journal-title":"Academic Forensic Pathology"},{"key":"1933_CR47","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.drugpo.2019.03.003","volume":"68","author":"SG Sherman","year":"2019","unstructured":"Sherman, S. G., Morales, K. B., Park, J. N., McKenzie, M., Marshall, B. D. L., & Green, T. C. (2019). Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence. International Journal of Drug Policy, 68, 46\u201353. https:\/\/doi.org\/10.1016\/j.drugpo.2019.03.003","journal-title":"International Journal of Drug Policy"},{"issue":"48","key":"1933_CR48","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.15585\/mmwr.mm7348a2","volume":"73","author":"LJ Tanz","year":"2024","unstructured":"Tanz, L. J., Stewart, A., Gladden, R. M., Ko, J. Y., Owens, L., & O\u2019Donnell, J. (2024). Detection of illegally manufactured fentanyls and carfentanil in drug overdose deaths - United States, 2021-2024. MMWR. Morbidity and Mortality Weekly Report, 73(48), 1099\u20131105. https:\/\/doi.org\/10.15585\/mmwr.mm7348a2","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"1","key":"1933_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-023-00767-0","volume":"20","author":"AS Tilhou","year":"2023","unstructured":"Tilhou, A. S., Zaborek, J., Baltes, A., Salisbury-Afshar, E., Malicki, J., & Brown, R. (2023). Differences in drug use behaviors that impact overdose risk among individuals who do and do not use fentanyl test strips for drug checking. Harm Reduction Journal, 20(1), Article 41. https:\/\/doi.org\/10.1186\/s12954-023-00767-0","journal-title":"Harm Reduction Journal"},{"key":"1933_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102900","volume":"84","author":"NP Weicker","year":"2020","unstructured":"Weicker, N. P., Owczarzak, J., Urquhart, G., Park, J. N., Rouhani, S., Ling, R., Morris, M., & Sherman, S. G. (2020). Agency in the fentanyl era: Exploring the utility of fentanyl test strips in an opaque drug market. International Journal of Drug Policy, 84, Article 102900. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102900","journal-title":"International Journal of Drug Policy"},{"issue":"2","key":"1933_CR51","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/jat\/bkaa181","volume":"45","author":"RE Wharton","year":"2021","unstructured":"Wharton, R. E., Casbohm, J., Hoffmaster, R., Brewer, B. N., Finn, M. G., & Johnson, R. C. (2021). Detection of 30 fentanyl analogs by commercial immunoassay kits. Journal of Analytical Toxicology, 45(2), 111\u2013116. https:\/\/doi.org\/10.1093\/jat\/bkaa181","journal-title":"Journal of Analytical Toxicology"},{"issue":"6","key":"1933_CR52","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.15425","volume":"5","author":"P Whitley","year":"2022","unstructured":"Whitley, P., LaRue, L., Fernandez, S. A., Passik, S. D., Dawson, E., & Jackson, R. D. (2022). Analysis of urine drug test results from substance use disorder treatment practices and overdose mortality rates, 2013\u20132020. JAMA Network Open, 5(6), Article e2215425. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.15425","journal-title":"JAMA Network Open"},{"issue":"1","key":"1933_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-022-00655-z","volume":"19","author":"GH Yoon","year":"2022","unstructured":"Yoon, G. H., Levengood, T. W., Davoust, M. J., Ogden, S. N., Kral, A. H., Cahill, S. R., & Bazzi, A. R. (2022). Implementation and sustainability of safe consumption sites: A qualitative systematic review and thematic synthesis. Harm Reduction Journal, 19(1), Article 73. https:\/\/doi.org\/10.1186\/s12954-022-00655-z","journal-title":"Harm Reduction Journal"},{"key":"1933_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2024.100889","volume":"39","author":"DT Zhu","year":"2024","unstructured":"Zhu, D. T., Bajaj, S. S., & Kerr, T. (2024). Supervised safe consumption sites - Lessons and opportunities for North America. Lancet Regional Health. Americas, 39, Article 100889. https:\/\/doi.org\/10.1016\/j.lana.2024.100889","journal-title":"Lancet Regional Health. Americas"}],"container-title":["Prevention Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11121-026-01933-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11121-026-01933-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11121-026-01933-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T03:39:43Z","timestamp":1785728383000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11121-026-01933-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1933"],"URL":"https:\/\/doi.org\/10.1007\/s11121-026-01933-z","relation":{},"ISSN":["1389-4986","1573-6695"],"issn-type":[{"value":"1389-4986","type":"print"},{"value":"1573-6695","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This activity was reviewed by CDC, deemed research not involving human subjects, and was conducted consistent with applicable federal law and CDC policy.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The findings and conclusions in this study are those of the authors and do not necessarily represent the official position of the U.S. Department of Health and Human Services, or the U.S. Centers for Disease Control and Prevention (Division of Laboratory Sciences). Use of trade names and commercial sources is for identification only and does not constitute endorsement by the U.S. Department of Health and Human Services, or the U.S. Centers for Disease Control and Prevention (Division of Laboratory Sciences). Photographs used in this report are sourced as CDC.","order":4,"name":"Ethics","label":"Disclaimers","group":{"name":"EthicsHeading","label":"Declarations"}}]}}